CS271343B2 - Method of new diphenylamine derivatives production - Google Patents

Method of new diphenylamine derivatives production Download PDF

Info

Publication number
CS271343B2
CS271343B2 CS875119A CS511987A CS271343B2 CS 271343 B2 CS271343 B2 CS 271343B2 CS 875119 A CS875119 A CS 875119A CS 511987 A CS511987 A CS 511987A CS 271343 B2 CS271343 B2 CS 271343B2
Authority
CS
Czechoslovakia
Prior art keywords
formula
hydrogen
compound
compounds
chlorine
Prior art date
Application number
CS875119A
Other languages
Czech (cs)
English (en)
Other versions
CS511987A2 (en
Inventor
Dezso Dr Ing Korbonits
Pal Dr Ing Kiss
Laszlo Dr Szekeres
Gyula Dr Papp
Gabor Dr Ing Kovacs
Andrea Ing Santa
Sandor Dr Virag
Eva Dr Udvari
Imre Ing Bata
Katalin Ing Marmarosi
Laszlo Dr Tardos
Peter Dr Kormoczy
Vera Dr Gergely
Zoltan Dr Vargai
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of CS511987A2 publication Critical patent/CS511987A2/cs
Publication of CS271343B2 publication Critical patent/CS271343B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58Radicals substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/16Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/27Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/29Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/58Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/42Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/43Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
CS875119A 1986-07-11 1987-07-06 Method of new diphenylamine derivatives production CS271343B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU862873A HU200591B (en) 1986-07-11 1986-07-11 Process for producing new diphenyl propylamine derivatives and pharmaceutical compositions comprising such compounds

Publications (2)

Publication Number Publication Date
CS511987A2 CS511987A2 (en) 1989-08-14
CS271343B2 true CS271343B2 (en) 1990-09-12

Family

ID=55982790

Family Applications (1)

Application Number Title Priority Date Filing Date
CS875119A CS271343B2 (en) 1986-07-11 1987-07-06 Method of new diphenylamine derivatives production

Country Status (28)

Country Link
US (1) US4988730A (ja)
EP (1) EP0253327B1 (ja)
JP (1) JP2637737B2 (ja)
KR (1) KR910000864B1 (ja)
CN (1) CN1019571B (ja)
AT (1) ATE75722T1 (ja)
AU (1) AU599117B2 (ja)
CA (1) CA1335104C (ja)
CS (1) CS271343B2 (ja)
DD (1) DD263980A5 (ja)
DE (1) DE3778770D1 (ja)
DK (1) DK360187A (ja)
ES (1) ES2032778T3 (ja)
FI (1) FI95128C (ja)
GR (1) GR3004518T3 (ja)
HR (1) HRP930508A2 (ja)
HU (1) HU200591B (ja)
IE (1) IE60028B1 (ja)
IL (1) IL83044A (ja)
NO (1) NO167658C (ja)
NZ (1) NZ221036A (ja)
PH (1) PH24514A (ja)
PL (1) PL150887B1 (ja)
PT (1) PT85304B (ja)
SI (1) SI8711299A8 (ja)
SU (2) SU1597096A3 (ja)
YU (1) YU46559B (ja)
ZA (1) ZA874812B (ja)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1205124B (it) * 1987-06-05 1989-03-15 Simens Soteta Italiana Medicin Composto attivo nella terapia carciovascolare
GB8823203D0 (en) * 1988-10-04 1988-11-09 Pfizer Ltd Therapeutic agents
JPH04329415A (ja) * 1991-04-30 1992-11-18 Fujitsu Ltd カード型入出力インタフェース装置及びシステム
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
JP2728564B2 (ja) * 1991-08-23 1998-03-18 エヌピーエス・ファーマシウティカルズ・インコーポレイテッド カルシウム受容体活性化分子
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
US5198548A (en) * 1992-01-30 1993-03-30 Warner-Lambert Company Process for the preparation of D(-) and L(+)-3,3-diphenylalanine and D(-) and L(+)-substituted 3,3-diphenylalanines and derivatives thereof
US6071970A (en) * 1993-02-08 2000-06-06 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US5962314A (en) * 1993-02-23 1999-10-05 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
DE69333527T2 (de) * 1993-02-23 2005-06-16 Brigham & Women's Hospital, Inc., Boston Calciumrezeptoraktive moleküle
US5492933A (en) * 1993-10-08 1996-02-20 Sepracor, Inc. Methods and compositions for treating urinary incontinence and other disorders using optically pure R-terodiline and hydroxylated derivatives thereof
ATE287390T1 (de) 1994-10-21 2005-02-15 Nps Pharma Inc Kalzium-rezeptor aktive verbindungen
ATE430123T1 (de) 1996-05-01 2009-05-15 Nps Pharma Inc Inorganische am ionen-rezeptor aktive verbindungen
SE9701144D0 (sv) * 1997-03-27 1997-03-27 Pharmacia & Upjohn Ab Novel compounds, their use and preparation
US6124507A (en) 1997-12-10 2000-09-26 Union Carbide Chemicals & Plastics Technology Corporation Electron donors
EP0957073A1 (en) 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
DE10315917A1 (de) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
FR2902789A1 (fr) * 2006-06-21 2007-12-28 Genfit Sa Derives de 1,3-diphenylpropane substitues, preparations et utilisations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1171930B (de) * 1961-08-10 1964-06-11 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung von koronardilatent wirksamen substituierten Propylaminderivaten
CH462189A (de) 1961-08-10 1968-09-15 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung von substituierten Propylaminderivaten
GB1032650A (en) * 1962-05-24 1966-06-15 Chinoin Gyogyszer Es Vegyeszet Improvements in or relating to diphenyl-propylamine derivatives
DD122967A1 (de) * 1975-07-10 1976-11-12 Lothar Luecke Hylamin-derivate

Also Published As

Publication number Publication date
SI8711299A8 (en) 1996-08-31
NZ221036A (en) 1990-05-28
IL83044A0 (en) 1987-12-31
HUT46651A (en) 1988-11-28
JP2637737B2 (ja) 1997-08-06
SU1588740A1 (ru) 1990-08-30
CA1335104C (en) 1995-04-04
PL266759A1 (en) 1988-09-01
EP0253327A3 (en) 1988-11-30
US4988730A (en) 1991-01-29
CN87104753A (zh) 1988-06-15
EP0253327A2 (de) 1988-01-20
FI873069A0 (fi) 1987-07-10
NO872880D0 (no) 1987-07-10
ES2032778T3 (es) 1993-03-01
HU200591B (en) 1990-07-28
NO167658B (no) 1991-08-19
JPS6372657A (ja) 1988-04-02
IL83044A (en) 1991-09-16
NO872880L (no) 1988-01-12
PT85304B (pt) 1990-03-30
NO167658C (no) 1991-11-27
YU46559B (sh) 1993-11-16
AU7552687A (en) 1988-01-14
DK360187D0 (da) 1987-07-10
AU599117B2 (en) 1990-07-12
HRP930508A2 (en) 1995-02-28
DD263980A5 (de) 1989-01-18
PT85304A (en) 1987-08-01
ATE75722T1 (de) 1992-05-15
FI95128C (fi) 1995-12-27
PH24514A (en) 1990-07-18
YU129987A (en) 1988-06-30
ZA874812B (en) 1988-10-26
CN1019571B (zh) 1992-12-23
DE3778770D1 (de) 1992-06-11
CS511987A2 (en) 1989-08-14
KR880001573A (ko) 1988-04-25
PL150887B1 (en) 1990-07-31
KR910000864B1 (ko) 1991-02-11
IE871866L (en) 1988-01-11
FI95128B (fi) 1995-09-15
IE60028B1 (en) 1994-05-18
EP0253327B1 (de) 1992-05-06
SU1597096A3 (ru) 1990-09-30
GR3004518T3 (ja) 1993-04-28
DK360187A (da) 1988-01-12
FI873069A (fi) 1988-01-12

Similar Documents

Publication Publication Date Title
CS271343B2 (en) Method of new diphenylamine derivatives production
EP0178874B1 (en) Alkylsulfonamidophenylalkylamines
LV12258B (en) DIAMINOCYCLOBUTE-3,4-DIONES AS GLUDO MUSCULAR RELAXATION
FR2504920A1 (fr) Derives phenylcyclobutyliques, leur procede de preparation et leur application therapeutique
FR2533924A1 (fr) Nouveaux derives du 4-(1h-indol-3-yl)a-methyl piperidine-1-ethanol, leurs sels, le procede de preparation, l'application a titre de medicaments et les compositions les renfermant
CH631162A5 (fr) Derives de la pyrrolidine, leur procede de preparation et leur application en therapeutique.
JPS6215062B2 (ja)
US4596827A (en) Alkylsulfonamidophenylalkylamine compounds used for treating arrhythmia
FI73206C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara alkyltiofenoxipropylaminer.
NO883070L (no) 4-amino-substituerte 1,2-dihydroksynaftalin-derivater.
IE49549B1 (en) Piperazine derivatives
JPS58116434A (ja) 置換されたフエノキシアルカノ−ルアミン類及びフエノキシアルカノ−ル−シクロアルキルアミン類
US4000192A (en) Pharmacologically active compounds
EP0339878A2 (en) Propanamine derivatives
CS203057B2 (en) Method of producing novel derivatives of n-/3,3-diphenyl propyl/-propylendiamine
US4101579A (en) Phenethanolamine ethers
EP0027679B1 (en) Substituted-5-((7-chloro-4-quinolinyl)amino)-3-(amino-methyl)-(1,1'-biphenyl)-2-ol compounds; processes for their production; and pharmaceutical compositions containing the compounds
JPS6252740B2 (ja)
EP0157762B1 (fr) Nouvelles piperidinoguanidines substituees, leur procede de preparation et les compositions pharmaceutiques en renfermant
US4727180A (en) Antihypertensive polyhalohydroxylisopropyl phenylalkanoic and phenylalkenoic acids, amides and esters and intermediates thereto
JPS6140247A (ja) フエニルエチルアミノプロピオフエノン誘導体
US3547974A (en) Aromatic propylamino cyano compounds
KR840001077B1 (ko) N⁴-카르바모일 피페라지노 프로판올 유도체의 제조방법
CS208458B2 (en) Method of making the now 1,4-cyclalkanoxazepines
CS263982B1 (cs) 4-(aminoalkoxy)dibenzo(b,e)thiepin-ll(6H)-ony a jejich hydrochloridy